Vortex Brands Co. (VTXB)

Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is March - February.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2018
Period Ending	Feb 28, 2022	Feb 28, 2021	Feb 29, 2020	Feb 28, 2018
Cash & Equivalents	0.05	-	-	0.11
Cash & Short-Term Investments	0.05	-	-	0.11
Other Current Assets	0.03	-	-	-
Total Current Assets	0.08	-	-	0.11
Property, Plant & Equipment	0.39	0.07	0.08	0.09
Total Assets	0.47	0.07	0.08	0.2
Accounts Payable	0.08	0.07	0.06	-
Accrued Expenses	0.51	0.6	0.4	-
Short-Term Debt	-	-	0	-
Total Current Liabilities	0.59	0.67	0.46	-
Total Liabilities	0.59	0.67	0.46	-
Common Stock	0.03	0.03	0.03	0.02
Additional Paid-In Capital	1.37	0.46	0.46	0.21
Retained Earnings	-1.53	-1.08	-0.87	-0.03
Comprehensive Income & Other	-0	-	-	-
Total Common Equity	-0.13	-0.6	-0.38	0.2
Shareholders' Equity	-0.13	-0.6	-0.38	0.2
Total Liabilities & Equity	0.47	0.07	0.08	0.2
Total Debt	-	-	0	-
Net Cash (Debt)	0.05	-	-0	0.11
Net Cash Per Share	0.00	-	-0.00	0.00
Filing Date Shares Outstanding	321.75	263	235	207.05
Total Common Shares Outstanding	321.75	263	235	207.05
Working Capital	-0.51	-0.67	-0.46	0.11
Book Value Per Share	-0.00	-0.00	-0.00	0.00
Tangible Book Value	-0.13	-0.6	-0.38	0.2
Tangible Book Value Per Share	-0.00	-0.00	-0.00	0.00
Machinery	0.45	0.08	0.09	0.1

Updated Oct 13, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.